Annual Cash & Cash Equivalents
$6.52 M
-$14.13 M-68.43%
December 31, 2023
Summary
- As of February 7, 2025, RKDA annual cash & cash equivalents is $6.52 million, with the most recent change of -$14.13 million (-68.43%) on December 31, 2023.
- During the last 3 years, RKDA annual cash & cash equivalents has fallen by -$7.52 million (-53.58%).
- RKDA annual cash & cash equivalents is now -77.28% below its all-time high of $28.68 million, reached on December 31, 2021.
Performance
RKDA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$3.94 M
-$1.57 M-28.49%
September 30, 2024
Summary
- As of February 7, 2025, RKDA quarterly cash and cash equivalents is $3.94 million, with the most recent change of -$1.57 million (-28.49%) on September 30, 2024.
- Over the past year, RKDA quarterly cash and cash equivalents has dropped by -$6.67 million (-62.91%).
- RKDA quarterly cash and cash equivalents is now -95.08% below its all-time high of $80.00 million, reached on June 30, 2015.
Performance
RKDA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RKDA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -68.4% | -62.9% |
| 3 y3 years | -53.6% | -82.9% |
| 5 y5 years | -45.7% | -82.9% |
RKDA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -77.3% | at low | -86.3% | +18.7% |
| 5 y | 5-year | -77.3% | at low | -91.0% | +18.7% |
| alltime | all time | -77.3% | +223.8% | -95.1% | +95.5% |
Arcadia Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.94 M(-28.5%) |
| Jun 2024 | - | $5.50 M(+65.9%) |
| Mar 2024 | - | $3.32 M(-49.1%) |
| Dec 2023 | $6.52 M(-68.4%) | $6.52 M(-38.6%) |
| Sep 2023 | - | $10.61 M(-21.3%) |
| Jun 2023 | - | $13.48 M(-41.4%) |
| Mar 2023 | - | $23.00 M(+11.4%) |
| Dec 2022 | $20.64 M(-28.0%) | $20.64 M(-9.1%) |
| Sep 2022 | - | $22.72 M(+7.0%) |
| Jun 2022 | - | $21.23 M(-13.5%) |
| Mar 2022 | - | $24.55 M(-14.4%) |
| Dec 2021 | $28.68 M(+104.3%) | $28.68 M(-19.3%) |
| Sep 2021 | - | $35.53 M(-19.2%) |
| Jun 2021 | - | $43.98 M(+33.9%) |
| Mar 2021 | - | $32.85 M(+133.9%) |
| Dec 2020 | $14.04 M(+66.8%) | $14.04 M(+37.7%) |
| Sep 2020 | - | $10.20 M(-32.0%) |
| Jun 2020 | - | $14.99 M(+15.6%) |
| Mar 2020 | - | $12.97 M(+54.1%) |
| Dec 2019 | $8.42 M | $8.42 M(-59.0%) |
| Sep 2019 | - | $20.54 M(+40.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $14.65 M(+40.3%) |
| Mar 2019 | - | $10.44 M(-13.0%) |
| Dec 2018 | $12.00 M(+31.5%) | $12.00 M(+79.9%) |
| Sep 2018 | - | $6.67 M(-31.0%) |
| Jun 2018 | - | $9.67 M(-52.7%) |
| Mar 2018 | - | $20.42 M(+123.8%) |
| Dec 2017 | $9.13 M(+353.3%) | $9.13 M(+211.4%) |
| Sep 2017 | - | $2.93 M(-78.2%) |
| Jun 2017 | - | $13.44 M(+77.8%) |
| Mar 2017 | - | $7.56 M(+275.5%) |
| Dec 2016 | $2.01 M(-91.6%) | $2.01 M(-80.8%) |
| Sep 2016 | - | $10.47 M(-61.7%) |
| Jun 2016 | - | $27.36 M(-7.4%) |
| Mar 2016 | - | $29.54 M(+23.2%) |
| Dec 2015 | $23.97 M(+44.7%) | $23.97 M(-61.9%) |
| Sep 2015 | - | $62.97 M(-21.3%) |
| Jun 2015 | - | $80.00 M(+609.4%) |
| Mar 2015 | - | $11.28 M(-31.9%) |
| Dec 2014 | $16.57 M(+484.5%) | $16.57 M(-21.7%) |
| Sep 2014 | - | $21.17 M(+646.7%) |
| Dec 2013 | $2.83 M(-47.0%) | $2.83 M |
| Dec 2012 | $5.35 M | - |
FAQ
- What is Arcadia Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Arcadia Biosciences?
- What is Arcadia Biosciences annual cash & cash equivalents year-on-year change?
- What is Arcadia Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Arcadia Biosciences?
- What is Arcadia Biosciences quarterly cash and cash equivalents year-on-year change?
What is Arcadia Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of RKDA is $6.52 M
What is the all time high annual cash & cash equivalents for Arcadia Biosciences?
Arcadia Biosciences all-time high annual cash & cash equivalents is $28.68 M
What is Arcadia Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, RKDA annual cash & cash equivalents has changed by -$14.13 M (-68.43%)
What is Arcadia Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RKDA is $3.94 M
What is the all time high quarterly cash and cash equivalents for Arcadia Biosciences?
Arcadia Biosciences all-time high quarterly cash and cash equivalents is $80.00 M
What is Arcadia Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, RKDA quarterly cash and cash equivalents has changed by -$6.67 M (-62.91%)